Prevalence and Determinant of Erectile Dysfunction in Type II Diabetes Mellitus and Healthy Men

Dorcas Serwaa; Folasade Adenike Bello; Kayode O. Osungbade; Charles Nkansah

doi:10.28991/SciMedJ-2021-0301-4

SciMedicine Journal (Mar 2021)

Prevalence and Determinant of Erectile Dysfunction in Type II Diabetes Mellitus and Healthy Men

Dorcas Serwaa,
Folasade Adenike Bello,
Kayode O. Osungbade,
Charles Nkansah

Affiliations

Dorcas Serwaa: Reproductive Biology Unit, Pan African University of Life and Earth Sciences Institute, University of Ibadan, Ibadan, Oyo State,
Folasade Adenike Bello: 2) Department of Obstetrics and Gynaecology, University College Hospital, Ibadan, Oyo State, Nigeria. 3) Department of Obstetrics and Gynaecology, University of Ibadan, Ibadan, Oyo State,
Kayode O. Osungbade: Community Medicine, College of Medicine, University College Hospital, Oyo State,
Charles Nkansah: 5) Clinical Laboratory Department, Nkenkaasu District Hospital, Nkenkaasu, Ghana. 6) Department of Medical Diagnostic, Faculty of Allied Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi,

DOI: https://doi.org/10.28991/SciMedJ-2021-0301-4
Journal volume & issue: Vol. 3, no. 1
pp. 23 – 34

Abstract

Read online

Erectile dysfunction is currently a growing health concern and one of the most prevalent sexual dysfunctions in men worldwide. Diabetes mellitus is considered a risk factor for developing ED. Therefore, this SHIM study was designed to assess the prevalence, severity and determinant of erectile dysfunction in type II diabetes mellitus patients and healthy men. This hospital-based cross-sectional study was conducted on 132 diabetic male patients and 66 healthy men at the Nkenkaasu hospital, Offinso North, Ghana between January-June, 2019. A pre-structured questionnaire and patients’ medical records were used to document relevant information. Erectile function was assessed using Sexual health inventory for men questionnaire. Data were analyzed using SPSS version 22.0. Chi-square test, binary and multivariable logistic regression analysis were used appropriately. The mean age of study participants was 57.94 ± 9.79 years. The overall mean score on the SHIM test was 12.42 ± 8.15 (range: 1–25), mean of 9.59±7.83 for the type II diabetics and 18.08±5.39 for non-diabetic men. The total erectile dysfunction (ED) prevalence was 81.8% (95% CI: 0.757, 0.869). ED was common in diabetics (70.4%) compared with healthy men (29.6%). Severe ED was 93.7% and 6.3% in the diabetic and non-diabetic men respectively. Multivariate logistic regression revealed that diabetic men with poor health-related quality of life had 3.48 times likelihood of having ED compared to their non-diabetic counterparts (AOR= 3.48, 95% CI; 1.284, 9.453). Very high erectile dysfunction was observed in our study participants. This is worrisome owing to the profound negative impact of ED on the quality of life and fertility of men. It is recommended that periodic assessment of erectile function should form part of routine diabetes care, focusing attention on the modifiable risk factors in preventing, delaying progression, or reversing established ED in persons. Doi: 10.28991/SciMedJ-2021-0301-4 Full Text: PDF

Published in SciMedicine Journal

ISSN: 2704-9833 (Online)
Publisher: Ital Publication
Country of publisher: Italy
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; Medicine: Public aspects of medicine
Website: https://scimedjournal.org

About the journal

Abstract

Keywords